In fact, PD-L1 determination plays a critical role mainly in the choice of first-line therapy, because tumors with high expression (≥50% tumor cells) can be treated by ICIs without the addition of chemotherapy [131,132,133]. The gene discussed is CD274; the disease is neoplasm.